×
Business / Stock Market

Forte Biosciences: FB-401 Could Become The First Line Topical Therapy In Atopic Dermatitis Market

Published Apr 08 2021 at 10:59 PM GMT
Seeking Alpha

Seeking Alpha @seekingalpha.com

Continue reading at seekingalpha.com
Key
Points
  • Forte Biosciences: FB-401 Could Become The First Line Topical Therapy In Atopic Dermatitis Market.
Credit
Tags
Continue reading at seekingalpha.com
Trending

Stats

  • Published Apr 8, 2021 10:59 PM GMT